A magnetic resonance and histological investigation of articular cartilage damage in early stage degenerative disease of the hip joint and evaluation of synthetic labro-chondral graft implantation

ISRCTN ISRCTN01688855
DOI https://doi.org/10.1186/ISRCTN01688855
Secondary identifying numbers 14799
Submission date
22/08/2013
Registration date
22/08/2013
Last edited
29/05/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Miss Jocelyn Buly
Scientific

Cardiology, Epsom and St Helier University Hospitals NHS Trust
St Helier Hospital Wrythe Lane
Carshalton
SM5 1AA
United Kingdom

Email jocelyn.buly@eoc.nhs.uk

Study information

Study designRandomised; Interventional; Design type: Not specified
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeDiagnostic
Participant information sheet Not available in web format, please use contact details to request a participant information sheet
Scientific titleA magnetic resonance and histological investigation of articular cartilage damage in early stage degenerative disease of the hip joint and evaluation of synthetic labro-chondral graft implantation (INTCLAPH)
Study acronymINTCLAPH
Study objectivesHealthy joints depend upon specialised cartilage (hyaline cartilage) that covers the surfaces of the articulating bones.

In the hip joint, the ball at the top of the thigh bone (femoral head) moves against a recess in the pelvis (the acetabulum). The acetabulum is deepened by the presence of a fibrous rim (the labrum) that helps to stabilise the joint and keep lubricating fluid between the rubbing surfaces.

When joints are damaged, the hyaline cartilage is lost and the joint becomes painful. In the hip, damage can be caused by repetitive injury to the labrum because the shapes of the ball and socket do not quite match. In time, the labrum begins to separate from the bony acetabular rim and the adjacent hyaline cartilage becomes unstable. As the damage progresses, the cartilage begins to peel away from the underlying bone, the femoral head then rubs against the damaged area and arthritis ensues.

Over the last few years, techniques have been developed, using keyhole surgery, that allow us to repair damage to the labrum and reshape the femoral head to avoid further injury. A number of strategies have also been developed to promote cartilage regeneration in areas of hyaline cartilage loss. These range from simply removing the damaged cartilage, making holes in the underlying bone (microfracturing) to the application of synthetic collagen graft patches. To date no one has compared these different strategies to find out which is the most effective. We propose to undertake a two-centre, prospective, randomised study, on patients with acetabular cartilage loss (adjacent to labral damage) and compare the four most commonly used repair strategies in order to find out which works best. Clinical outcome, X-rays, Computerised tomography (CT), Magnetic Resonance (MR) and biomarkers (blood and urine tests) will be used to evaluate the study subjects.
Ethics approval(s)13/LO/0753
Health condition(s) or problem(s) studiedTopic: Musculoskeletal; Subtopic: Musculoskeletal (all Subtopics); Disease: Non-inflammatory Joint Disorders
Interventiontbc, tbc
Intervention typeOther
Primary outcome measuretbc; Timepoint(s): tbc
Secondary outcome measuresNot provided at time of registration
Overall study start date15/08/2013
Completion date15/01/2015

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participantsPlanned Sample Size: 45; UK Sample Size: 45
Key inclusion criteria1. History of hip pain.
2. Tönnis grade 0 or 1 radiographic changes.
3. Hip Joint Space Width (JSW) > 2 mm.
4. Arthroscopic confirmation of:
4.1. Labro-chondral split
4.2. Chondral defect grade 3 and 4 (Outerbridge, ICRS & UCL Classifications)
4.3. Chondral defect size range 0.5 – 4.0 cm2.
5. Ability to provide informed written consent.
Target Gender: Male & Female; Upper Age Limit 55 years ; Lower Age Limit 18 years
Key exclusion criteria1. OA Grade > 1 (Tönnis scale)
2. Inflammatory joint disease
3. Previous dislocation or fracture of the affected hip
4. Previous non-arthroscopic surgery to the affected hip
5. History of back pain
6. Age <18 years and > 55 years
7. BMI > 30
8. Hip joint space = 2 mm
9. Previous hip joint sepsis or osteomyelitis
10. Metabolic bone disease
11. Osteoporosis
12. Avascular necrosis
13. Associated neurological disease
14. Diabetes
15. Pregnancy
16. Chronic use of narcotics or oral steroids
17. Heavy alcohol intake on a regular basis
18. Inability to give consent or cooperate with the study protocol
19. Non-English speaking patients
20. Patients who move outside United Kingdom
Date of first enrolment15/08/2013
Date of final enrolment15/01/2015

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Epsom and St Helier University Hospitals NHS Trust
Carshalton
SM5 1AA
United Kingdom

Sponsor information

St George's University of London (UK)
University/education

Cranmer Terrace
London
SW17 0RE
England
United Kingdom

ROR logo "ROR" https://ror.org/040f08y74

Funders

Funder type

Charity

Orthopaedic Research UK; Grant Codes: 491
Private sector organisation / For-profit companies (industry)
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
HRA research summary 28/06/2023 No No

Editorial Notes

29/05/2020: No publications found.
12/01/2017: No publications found, verifying study status with principal investigator.